MEASURING THE UNMEASURABLE

Breaking the One-Way Mirror of Private Equity

For the past decade, my work has been purely diagnostic—stepping beyond the standard 'Streetlight Effect' of financial reporting to quantify the unmodelled operational realities that silently hollow out enterprise value. I built the Organisational CT Scan to reverse-engineer these hidden mechanics, helping teams anchor due diligence in measurable friction recovery rather than just treating surface-level metrics.

It is the difference between handing a management team a financial painkiller to temporarily mask the symptoms, versus isolating the root-cause contagion that is actually hollowing out the host.

This relentless focus on exposing the 'unseen' didn't start in a boardroom. It is deeply personal.

For 40+ years, I have lived with Type 1 Diabetes. The established medical 'playbook' dictated I eat 360 grams of carbohydrates daily. This prescribed diet guarantees hyperglycaemic spikes, just as the massive insulin doses required to counteract them guarantee hypoglycaemic crashes. Both extremes silently hollow out the human body. This is the 'playbook' roller-coaster we are expected to endure—where losing a limb is considered an acceptable outcome. It is a playbook that literally prescribes the exact kryptonite that destroys the body. I had to know why.

Just over ten years ago, I rejected this 'normal'. I questioned the truth and reverse-engineered how the system evolved over a century to define the playbook they blindly follow today. When I finally pushed against the system and forced my doctors to give me a simple, fast, non-invasive CAC Scan—a Coronary Artery Calcium (CAC) scan is a non-invasive, low-dose CT scan that measures the amount of calcified plaque in the heart's arteries, providing a score that helps predict future heart attack risk—to prove my internal health, the results shattered their assumptions.

Yet, 99% of the medical ecosystem isn't interested because the truth sits outside their 'Streetlight Effect'—a truth that doesn’t make the industry money. They blindly follow the prescribed 'accepted' lie. The system is rigged in their favour, giving them plausible deniability and liability cover.

The Private Equity Playbook

At the exact same time I began applying my diagnostic lens to corporate assets, I saw the exact same rigged system.

I saw Private Equity’s vast, invisible spider’s web influencing and hollowing out the brands everyday people use—manipulating those assets to serve General Partner (GP) incentives rather than the asset's actual health. The Private Equity industry is structurally misaligned. Taking on a trillion-dollar industry means facing an establishment that desperately needs the current narrative to remain true.

GPs use debt, manipulate IRR, and ride market tailwinds to simulate 'Alpha'—charging astronomical ‘2 and 20’ fees for what is actually just market 'Beta'. Like my doctors over the years, they are following a global playbook that enriches the system while destroying the host, relying on opaque shadow data to hide the reality.

“To see the invisible, we simply need new rulers.” — Morten J. Sørensen

Because internal emotional and operational friction is hard to measure, GPs easily hide behind this shadow data. Without a new ruler for operational reality, Limited Partners (LPs)—the pension funds and sovereign wealth funds supplying the capital—cannot verify if a GP actually generated true value (Skill) or simply rode a wave of leverage and market tailwinds (Luck).

It is time to break the one-way mirror of Private Equity.

The Diagnostic Baseline (AES)

If we are to isolate GP skill, we must measure unseen operational reality, not just financial outputs. A personal cardiac CT scan—revealing internal homeostatic health long before external symptoms appear—sparked the Genesis breakthrough.

Using this concept, we can establish an independent, externally verifiable Asset Efficiency Score (AES). Its inverse, the Asset Inefficiency Score (AIS), quantifies the exact volume of unpriced value actively trapped within a company's human and operational friction, transforming it into a measurable metric:

AIS = 1 − AES

The Diagnostic Baseline. Where AES represents the independent, externally verifiable Asset Efficiency Score, and its inverse, AIS, quantifies the exact volume of unpriced value actively trapped within a company's human and operational friction.

This establishes an uninfluenced, true operational baseline of the asset—completely independent of its financial market valuation and, crucially, agnostic of the GP's self-reported data.

The Hypothesis: The Variance of Skill

Since we can measure an independent operational baseline friction, we can isolate the GP's actual impact without relying on their data room.

Line chart illustrating the Delta AES Variance over a 72-month Private Equity hold period. It contrasts 'True Alpha' (operational skill improving the AES_Baseline) against 'The Alpha Illusion' (operational decay masked by market luck).

We establish the baseline prior to GP intervention (AES 1) and conduct secondary scans during and following their ownership period (AES 2). That longitudinal variance mathematically strips out market noise to reveal true operational skill and value creation:

ΔAES_Variance = AES₂ − AES₁

The Variance of Skill. Where AES₁ is the baseline operational friction prior to GP intervention, and AES₂ is the secondary scan during or following their ownership period. The longitudinal variance mathematically strips out market noise to reveal true operational skill.

A detailed infographic visually representing the core three-phase engine of the proprietary PEPI Alpha Key™ framework. This process engine bypasses GP shadow data through an independent Organisational CT Scan, mathematically derives the Asset Efficiency Score (AES), executes operational improvements, and finally certifies the longitudinal variance (ΔAES_Variance = AES₂ − AES₁) to mathematically isolate true operational skill from market luck. This empowers LPs to independently verify value creation without GP input.

Protecting the LPs: The Implication of the Ruler

ΔAES_Variance

The Alpha Isolation Test. Used to strip away market exit multiples (M) and sector Beta. If EV expands but ΔAES_Variance is static, the outperformance is market luck (The Alpha Illusion). A positive ΔAES_Variance isolates true, proprietary skill (True Alpha).

By measuring Delta AES_Variance, we effectively strip away market exit multiples (M) and sector Beta.

• The Alpha Illusion: If Enterprise Value expands but Delta AES_Variance remains static, the outperformance is mathematically proven to be market luck. The GP did not fix the asset; they just held it, manipulating the balance sheet while charging astronomical fees.

• True Alpha: A positive Delta AES_Variance isolates true, proprietary skill, providing the missing empirical proof required to potentially justify performance fees.

Because the AIS exposes strictly hidden, trapped EBITDA, resolving this friction is a positive-sum value creator flowing directly into unpriced EV.

The Retroactive Audit: Nothing is Safe

Crucially, because this diagnostic is completely agnostic and externally verifiable, it bypasses the GP's shadow data entirely. LPs no longer have to ask the GP for permission to understand the health of their own capital.

But the implications go far beyond active portfolios. Because the diagnostic relies on independent, uninfluenced metrics, LPs can retroactively build a GP’s historical AUM performance chart. They can effectively audit a GP's legacy funds to mathematically prove whether past ‘Alpha’ was generated by operational skill or merely fuelled by low interest rates and financial engineering.

Nothing is safe from the possibilities of an Organisational CT Scan.

We cannot fix a rigged system by asking the architects of that system for their data. To see the invisible, we simply need new rulers.